Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

PotNetwork Holdings, Inc. Changing Name To Biotech Hemp, Inc. and Moves Forward on Filings In Preparation for Uplisting


Posted on: 02 Jul 18

Company to Rapidly Complete FINRA Application, and Form 10 To Become Fully Reporting SEC Issuer

FT LAUDERDALE, Fla., July 02, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holdings, Inc. (OTC Pink:POTN) announces that on June 27, 2018, the Company, a Colorado corporation, filed an amendment to its Articles of Incorporation in the state to change its name from PotNetwork Holdings, Inc. to “BioTech Hemp, Inc.” 

In connection with the name change, the Company is now in the process of preparing its filing with FINRA for a name and symbol change; and in anticipation, has obtained a new CUSIP number to go in effect at the time these changes are effective.  The Company plans  to complete the FINRA submission by the end of this week. Implementation of the name change and symbol change, is subject to FINRA review, approval and processing.

Separately, although the Company’s Form 10 filing to become a fully reporting issuer with the Securities and Exchange Commission (“SEC”) was planned for completion by June 30th, it is now planned to be submitted as quickly as possible in early July following its finalization, internal review and review by the Company’s PCAOB auditor. Once the Company’s Form 10 filing is deemed effective by the SEC, the Company will begin the process to uplist to the OTCQB market tier.

With sales of over $10 million generated by our hemp-derived CBD product lines in the first five months of 2018,  which far exceeds the same period in 2017, the name change underscores the Company’s strengthening identity as a dominant player in the CBD Industry.

About Diamond CBD Inc.: Diamond CBD focuses on the research, development, and multinational marketing of premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives. Diamond CBD’s team consists of hemp industry pioneers and natural product experts, chemists, doctors and scientists, dedicated to producing the finest and purest cannabidiol (CBD) oils. The result is a robust selection considered among the most powerful natural CBD oils, tinctures, edibles, and vape liquids found anywhere. For more information, please visit its website at www.DiamondCBD.com.

About PotNetwork Holdings, Inc: PotNetwork Holdings, Inc. (OTC Pink:POTN) is a publicly traded company that acts as a holding company for its subsidiaries, First Capital Venture Co., the owner of Diamond CBD, Inc., the maker of Diamond CBD oils.

Safe Harbor Act: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter forward-looking statements, whether as a result of new information, future events or otherwise.

Contact: PotNetwork Holdings, Inc. Investor Relations: Marisol Elwell

1-800-915-3060 investor@PotNetworkHolding.com

GlobeNewswire
globenewswire.com

Last updated on: 02/07/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.